Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
Béré Diallo, Caitlín Ní Chasaide, Ting Y. Wong, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
Gabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, et al.
Science Advances (2023) Vol. 9, Iss. 38
Open Access | Times Cited: 31
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
Advances and future perspectives of intranasal drug delivery: A scientometric review
Dong Xu, Xujiao Song, Xue Chen, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 366-384
Closed Access | Times Cited: 12
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
Katherine S. Lee, Ting Y. Wong, Brynnan P. Russ, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273430-e0273430
Open Access | Times Cited: 34
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
Kairat Tabynov, Maxim Solomadin, Nurkeldi Turebekov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in mice
Dylan T. Boehm, Kaitlyn M. Landreth, Emel Sen-Kilic, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Chitosan-coated nanostructured lipid carriers for intranasal delivery of sinapic acid in Aβ1–42 induced C57BL/6 mice for Alzheimer's disease treatment
A Prabakaran, Debarati Rakshit, Inklisan Patel, et al.
International Journal of Biological Macromolecules (2025), pp. 141136-141136
Closed Access
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
Gabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
Obesity and metabolic dysfunction drive sex-associated differential disease profiles in hACE2-mice challenged with SARS-CoV-2
Katherine S. Lee, Brynnan P. Russ, Ting Y. Wong, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105038-105038
Open Access | Times Cited: 15
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
Ting Y. Wong, Brynnan P. Russ, Katherine S. Lee, et al.
mSphere (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 14
Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2
Wei‐Chiao Huang, Kevin Chiem, Luis Martínez‐Sobrido, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 1035-1035
Open Access | Times Cited: 14
Longitudinal temperature measurement can determine humane endpoints in BALB/c mouse models of ESKAPEE infection
Randal Scott Dudis, Ting Y. Wong, Mariel G. Escatte, et al.
Virulence (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Intratumoral administration of mRNA-1273 vaccine delays melanoma growth in mice
Dylan T. Boehm, Kaitlyn M. Landreth, Emel Sen-Kilic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
A Dual‐Adjuvanted Parenteral‐Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS‐CoV‐2 in Mice
Bhawana Pandey, Zhengying Wang, Angela Jimenez, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
Katherine S. Lee, Nathaniel A. Rader, Olivia A. Miller-Stump, et al.
Vaccine (2023) Vol. 41, Iss. 34, pp. 5003-5017
Open Access | Times Cited: 7
Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists
Gang Hu, David J. Varisco, Sayan Das, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18119-e18119
Open Access | Times Cited: 6
BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models
Megan A. DeJong, M. Allison Wolf, Graham J. Bitzer, et al.
Infection and Immunity (2024) Vol. 92, Iss. 3
Open Access | Times Cited: 1
Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice
Nathaniel A. Rader, Katherine S. Lee, Andrea N. Loes, et al.
Vaccine X (2024) Vol. 20, pp. 100543-100543
Open Access | Times Cited: 1
Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection
Deok‐Hwan Kim, Jiho Lee, Da-Ye Lee, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 921-921
Open Access | Times Cited: 1
The identification and characterization of novel and improved antigens for next-generation pertussis vaccines
Gage M. Pyles
(2024)
Open Access | Times Cited: 1
Novel broadly reactive monoclonal antibody protects against Pseudomonas aeruginosa infection
Margalida Mateu-Borrás, Spencer R. Dublin, Jason Kang, et al.
Infection and Immunity (2024) Vol. 93, Iss. 1
Open Access | Times Cited: 1
Bibliometric analysis of RNA vaccines for cancer
Yang Xue, Jian Kang, Zhaohui Xing, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
Sergio A. Rodriguez‐Aponte, Neil C. Dalvie, Ting Y. Wong, et al.
Vaccine (2022) Vol. 41, Iss. 5, pp. 1108-1118
Open Access | Times Cited: 6
Optimizing the Immunogenicity of HIV Vaccines by Adjuvants – NIAID Workshop Report
Anjali Singh, César Boggiano, Michael A. Eller, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4439-4446
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top